Analyze Diet
Equine veterinary journal2017; 50(4); 452-456; doi: 10.1111/evj.12767

Protein biomarker of cell proliferation determines survival to discharge in cases of equine large colon volvulus.

Abstract: Progenitor cells play critical roles in epithelial repair following ischaemic injury. Protein biomarkers have been used to identify intestinal progenitor cell subpopulations. This study aims to determine if a critical number of intestinal progenitor cells can predict tissue viability and survival to discharge of large colon volvulus (LCV) cases. Objective: The objectives were to 1) identify intestinal progenitor cell subpopulations using biomarkers: proliferating cell nuclear antigen (PCNA), sex determining region Y box 9 (SOX9), phospho-histone H3 (PHH3) and Ki-67, 2) define cut-off values for critical numbers of positive cells and 3) determine if survival to discharge is associated with cut-off values. Methods: Retrospective cohort study. Methods: Adult horses admitted to the Farm and Equine Veterinary Medical Center at NC State's Veterinary Hospital and Peterson and Smith Equine Hospital between 2006 and 2016 that underwent an exploratory coeliotomy with a diagnosis of LCV of ≥360 degrees, had pelvic flexure biopsy and that recovered from general anaesthesia were selected for inclusion in the study. Immunohistochemical analyses were performed and positive cells were counted. Optimal cut-off values were determined using receiver operator curves. A Fisher's exact test was used to associate cut-off values with survival to discharge. Results: In this study, 23 cases of LCV ≥360° were included. Of 23 horses, 13 (57%) survived to discharge. A cut-off value of <2.1 PHH3 positive cells per crypt correctly predicted death with 100% sensitivity (95% CI; 69.15-100%) and 84.62% specificity (95% CI; 54.55-98.08%). LCV cases with <2.1 PHH3 positive cells per crypt were 96.6 times more likely to die (95% CI; 4.14-2255 and P < 0.0001). Biomarkers PCNA, SOX9 and Ki-67 did not predict short-term survival. Conclusions: The population size was small. Conclusions: PHH3 immunohistochemical analysis may assist in more accurate prediction of survival to hospital discharge of LCV cases. The summary is available in Spanish - see Supporting Information.
Publication Date: 2017-11-27 PubMed ID: 29032573PubMed Central: PMC5899956DOI: 10.1111/evj.12767Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigates the role of intestial progenitor cells in determining the survival of horses suffering from a serious intestinal injury called large colon volvulus (LCV). The study specifically looks at certain biomarkers (proteins as an indicator of specific cell activity), and their ability to predict the survival of an inflicted animal.

Study Objectives

The research had three main objectives:

  • Identify which subpopulations of intestinal progenitor cells are indicated by biomarkers: PCNA, SOX9, PHH3, and Ki-67.
  • Establish critical numbers of these biomarker-positive cells that would predict the survival to discharge of LCV cases.
  • Examine if survival to discharge is linked to the established cut-off values of these biomarker-positive cells.

Methods

The research was a retrospective cohert study, meaning it looked back at past cases to draw conclusions. The study consisted of adult horses that were admitted to two different hospitals suffering from LCV and underwent a specific surgery (an exploratory coeliotomy). All included horses recovered from general anaesthesia. The researchers performed immunohistochemical analyses (tests to identify particular molecules in cells of a tissue) where they counted cells that tested positively for the targeted biomarkers. Statitical methods were used to determine optimal cut-off values of biomarker-positive cells and to associate these values with the animals’ survival.

Results

The study was conducted on 23 cases of LCV. Among these, 13 horses, or 57%, managed to survive up to discharge. A specific cut-off value of less than 2.1 PHH3 positive cells per crypt (a part of the intestine) could predict death with very high certainty. On the contrary, PCNA, SOX9, and Ki-67 biomarkers did not seem to play a direct role in short-term survival.

Conclusion

Though the population size for the study was small, it suggested that the PHH3 biomarker analysis can aid in more accurate predictions of a horse’s survival chances after suffering from LCV. It is important to remember that while the findings suggest a correlation, the results do not prove causation, and further research may be necessary before this finding can be applied widely.

Cite This Article

APA
Kucera CR, Stranahan LW, Hughes F, Blikslager AT, Gonzalez LM. (2017). Protein biomarker of cell proliferation determines survival to discharge in cases of equine large colon volvulus. Equine Vet J, 50(4), 452-456. https://doi.org/10.1111/evj.12767

Publication

ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 50
Issue: 4
Pages: 452-456

Researcher Affiliations

Kucera, C R
  • Department of Clinical Sciences, North Carolina State University College of Veterinary Medicine, Raleigh, North Carolina, USA.
Stranahan, L W
  • Department of Clinical Sciences, North Carolina State University College of Veterinary Medicine, Raleigh, North Carolina, USA.
Hughes, F
  • Peterson and Smith Equine Hospital, Ocala, Florida, USA.
Blikslager, A T
  • Department of Clinical Sciences, North Carolina State University College of Veterinary Medicine, Raleigh, North Carolina, USA.
Gonzalez, L M
  • Department of Clinical Sciences, North Carolina State University College of Veterinary Medicine, Raleigh, North Carolina, USA.

MeSH Terms

  • Animals
  • Biomarkers
  • Cell Proliferation / physiology
  • Cohort Studies
  • Colonic Diseases / veterinary
  • Female
  • Gene Expression Regulation
  • Horse Diseases / blood
  • Horses
  • Intestinal Volvulus / metabolism
  • Intestinal Volvulus / pathology
  • Intestinal Volvulus / veterinary
  • Male
  • ROC Curve
  • Retrospective Studies
  • Survival Analysis

Grant Funding

  • K01 OD019911 / NIH HHS
  • T35 OD011070 / NIH HHS

References

This article includes 20 references
  1. Snyder JR, Pascoe JR, Olander HJ, Spier SJ, Meagher DM, Bleifer DR. Strangulation volvulus of the ascending colon in horses.. J. Am. Vet. Med. Assoc. 1989;195:757–764.
    pubmed: 2793543
  2. Levi O, Affolter VK, Benak J, Kass PH, Le Jeune SS. Use of pelvic flexure biopsy scores to predict short-term survival after large colon volvulus.. Vet. Surg. 2012;41:582–588.
    pubmed: 22571759
  3. Ducharme NG, Hackett RP, Ducharme GR, Long S. Surgical treatment of colic results in 181 horses.. Vet. Surg. 1983;12:206–209.
  4. Suthers JM, Pinchbeck GL, Proudman CJ, Archer DC. Survival of horses following strangulating large colon volvulus.. Equine Vet. J. 2013;45:219–223.
    pubmed: 22994687
  5. Proudman CJ, Edwards GB, Barnes J, French NP. Modelling long-term survival of horses following surgery for large intestinal disease.. Equine Vet. J. 2005;37:366–370.
    pubmed: 16028630
  6. Johnston K, Holcombe SJ, Hauptman JG. Plasma lactate as a predictor of colonic viability and survival after 360° volvulus of the ascending colon in horses.. Vet. Surg. 2007;36:563–567.
    pubmed: 17686130
  7. Gonzalez LM, Fogel CA, Baker WT, Hughes FE, Law JM, Motsinger-Reif AA, Blikslager AT. Operative factors associated with short-term outcome in horses with large colon volvulus: 47 cases from 2006 to 2013.. Equine Vet. J. 2015;47:279–284.
    pmc: PMC4198525pubmed: 24735170
  8. van Hoogmoed L, Snyder JR, Pascoe JR, Olander HJ. Use of pelvic flexure biopsies to predict survival after large colon torsion in horses.. Vet. Surg. 2000;29:572–577.
    pubmed: 11098791
  9. Gonzalez LM, Kinnin LA, Blikslager AT. Characterization of discrete equine intestinal epithelial cell lineages.. Am. J. Vet. Res. 2015;76:358–366.
    pmc: PMC4517574pubmed: 25815577
  10. Barker N, van der Wetering M, Clevers H. The intestinal stem cell.. Gene Dev. 2008;22:1856–1864.
    pmc: PMC2735277pubmed: 18628392
  11. Dekaney CM, Fong JJ, Rigby RJ, Lund PK, Henning SJ, Helmrath MA. Expansion of intestinal stem cells associated with long-term adaptation following ileocecal resection in mice.. Am. J. Physiol.-Gastr. L. 2007;293:1013–1022.
    pubmed: 17855764
  12. van Hoogmoed L, Snyder JR, Pascoe JR, Olander HJ. Evaluation of uniformity of morphological injury of the large colon following severe colonic torsion.. Equine Vet. J. 2000;32(Suppl. 32):98–100.
    pubmed: 11202394
  13. Rowe EL, White NA, Buechner-Maxwell V, Robertson JL, Ward DL. Detection of apoptotic cells in intestines from horses with and without gastrointestinal tract disease.. Am. J. Vet. Res. 2003;64:982–988.
    pubmed: 12926589
  14. Malkas LH, Herbert BS, Waleed A, Dobrolecki LE, Liu Y, Agarwal B, Hoelz D, Badve S, Schnaper L, Arnold RJ, Mechref Y, Novoty MV, Loehrer P, Goulet RJ, Hickey RJ. A cancer-associated PCNA expressed in breast cancer has implications as a potential biomarker.. PNAS 2006;103:19472–19477.
    pmc: PMC1697829pubmed: 17159154
  15. Scholzen T, Gerdes J. The ki-67 protein: From the known and the unknown.. J. Cell Physiol. 2000;182:311–322.
    pubmed: 10653597
  16. Gonzalez LM, Williamson I, Piedrahita JA, Blikslager AT, Magness ST. Cell lineage identification and stem cell culture in a porcine model for the study of intestinal epithelial regeneration.. PLOS One 2013;8:e66465.
    pmc: PMC3696067pubmed: 23840480
  17. Roche KC, Gracz AD, Liu XF, Newton V, Akiyama H, Magness ST. SOX9 maintains reserve stem cells and preserves radioresistance in mouse small intestine.. Gastroenterology 2015;149:1553–1563.
    pmc: PMC4709179pubmed: 26170137
  18. Gerring Z, Pearson JE, Morrin HR, Robinson BA, Harris GC, Walker LC. Phosphohistone H3 outperforms Ki67 as a marker of outcome for breast cancer patients.. Histopathology 2015;67:538–547.
    pubmed: 25728258
  19. Hans F, Demitrov F. Histone H3 phosphorylation and cell division.. Oncogene 2001;20:3021–3027.
    pubmed: 11420717
  20. Alkhasawneh A, Reith JD, Toro TZ, Ayed AO, Lu X, George TJ, Duckworth LV. Interobserver variability of mitotic index and utility of PHH3 for risk stratification in gastrointestinal stromal tumors.. Am. J. Clin. Pathol. 2015;143:385–392.
    pubmed: 25696796